Skip to main content

Table 1 Definition of Metabolic syndrome by using NCEP/ATPIII and IDF criteria

From: Prevalence of metabolic syndrome and associated factors among patient with type 2 diabetes mellitus in Ethiopia, 2023: asystematic review and meta analysis

 

NCEP/ATPIII

IDF

Absolutely required

None

Central obesity (waist circumference): 94 cm (M) and ≥ 80 cm (F)

Criteria

Any three of the five criteria below

Obesity, plus two of the four criteria below

Obesity

Waist circumference: >40 inches (M) and > 35 inches (F)

Central obesity already required

Hyperglycemia

Fasting glucose > 100 mg/dl or Rx

Fasting glucose > 100 mg/dl

Dyslipidemia

TG > 150 mg/dl or Rx

TG > 150 mg/dl or Rx

Dyslipidemia (second, separate criteria)

HDL-C: <40 mg/dl (M) and < 50 mg/dl (F) or Rx

HDL-C: <40 mg/dl (M) and < 50 mg/dl (F) or Rx

Hypertension

> 130 mmHg systolic or > 85 mmHg diastolic or Rx

> 130 mmHg systolic or > 85 mmHg diastolic or Rx

  1. *Rx, pharmacologic treatment; *NCEP/ATPIII, National Cholesterol Education Program–Adult Treatment Panel III; *IDF, International Diabetes Federation; *TG, triglyceride; *HDL-C, high-density lipoprotein cholesterol